CypD

The key to the death door

Shaik M. Fayaz, Yanamala V. Raj, Rajanikant G. Krishnamurthy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Numerous studies have deciphered the importance of Cyclophilin D (CypD/ peptidyl prolyl scis-trans isomerase F) in the formation and regulation of mitochondrial permeability transition pore (MPTP), implicated in the cell death mechanisms in various neurological diseases. Decrease in the ATP and increase in the calcium levels are the most common aftermath consequences that are observed in these diseases. Increased calcium level leads to the persistent opening of MPTP and cell death, which is mediated by CypD. However, the underlying mechanisms that contribute to the abnormal calcium homeostasis in different diseases remain elusive. In this review, we attempted to connect the disruption of mitochondrial bioenergetics with abnormal calcium levels and MPTP. Further, various proteins that interact with the CypD and the subsequent consequences have been described. All the cell death pathways in various neurological disorders merge at CypD, which acts as a key regulatory protein in cellular demise. Agents inhibiting CypD may have a therapeutic potential for treating neurological disorders such as Alzheimer’s disease, Parkinson’s disease and cerebral ischemia. Further, the knowledge regarding the pathophysiological processes involved in CypD-regulated MPTP and cell death would assist in battling with these diseases.

Original languageEnglish
Pages (from-to)654-663
Number of pages10
JournalCNS and Neurological Disorders - Drug Targets
Volume14
Issue number5
DOIs
Publication statusPublished - 01-06-2015

Fingerprint

Cell Death
Calcium
Nervous System Diseases
Isomerases
Brain Ischemia
Energy Metabolism
Parkinson Disease
Alzheimer Disease
Proteins
Homeostasis
Adenosine Triphosphate
mitochondrial permeability transition pore
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Pharmacology

Cite this

Fayaz, Shaik M. ; Raj, Yanamala V. ; Krishnamurthy, Rajanikant G. / CypD : The key to the death door. In: CNS and Neurological Disorders - Drug Targets. 2015 ; Vol. 14, No. 5. pp. 654-663.
@article{60b44017668344459e6ebfcc135419a0,
title = "CypD: The key to the death door",
abstract = "Numerous studies have deciphered the importance of Cyclophilin D (CypD/ peptidyl prolyl scis-trans isomerase F) in the formation and regulation of mitochondrial permeability transition pore (MPTP), implicated in the cell death mechanisms in various neurological diseases. Decrease in the ATP and increase in the calcium levels are the most common aftermath consequences that are observed in these diseases. Increased calcium level leads to the persistent opening of MPTP and cell death, which is mediated by CypD. However, the underlying mechanisms that contribute to the abnormal calcium homeostasis in different diseases remain elusive. In this review, we attempted to connect the disruption of mitochondrial bioenergetics with abnormal calcium levels and MPTP. Further, various proteins that interact with the CypD and the subsequent consequences have been described. All the cell death pathways in various neurological disorders merge at CypD, which acts as a key regulatory protein in cellular demise. Agents inhibiting CypD may have a therapeutic potential for treating neurological disorders such as Alzheimer’s disease, Parkinson’s disease and cerebral ischemia. Further, the knowledge regarding the pathophysiological processes involved in CypD-regulated MPTP and cell death would assist in battling with these diseases.",
author = "Fayaz, {Shaik M.} and Raj, {Yanamala V.} and Krishnamurthy, {Rajanikant G.}",
year = "2015",
month = "6",
day = "1",
doi = "10.2174/1871527314666150429113239",
language = "English",
volume = "14",
pages = "654--663",
journal = "CNS and Neurological Disorders - Drug Targets",
issn = "1871-5273",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

CypD : The key to the death door. / Fayaz, Shaik M.; Raj, Yanamala V.; Krishnamurthy, Rajanikant G.

In: CNS and Neurological Disorders - Drug Targets, Vol. 14, No. 5, 01.06.2015, p. 654-663.

Research output: Contribution to journalArticle

TY - JOUR

T1 - CypD

T2 - The key to the death door

AU - Fayaz, Shaik M.

AU - Raj, Yanamala V.

AU - Krishnamurthy, Rajanikant G.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Numerous studies have deciphered the importance of Cyclophilin D (CypD/ peptidyl prolyl scis-trans isomerase F) in the formation and regulation of mitochondrial permeability transition pore (MPTP), implicated in the cell death mechanisms in various neurological diseases. Decrease in the ATP and increase in the calcium levels are the most common aftermath consequences that are observed in these diseases. Increased calcium level leads to the persistent opening of MPTP and cell death, which is mediated by CypD. However, the underlying mechanisms that contribute to the abnormal calcium homeostasis in different diseases remain elusive. In this review, we attempted to connect the disruption of mitochondrial bioenergetics with abnormal calcium levels and MPTP. Further, various proteins that interact with the CypD and the subsequent consequences have been described. All the cell death pathways in various neurological disorders merge at CypD, which acts as a key regulatory protein in cellular demise. Agents inhibiting CypD may have a therapeutic potential for treating neurological disorders such as Alzheimer’s disease, Parkinson’s disease and cerebral ischemia. Further, the knowledge regarding the pathophysiological processes involved in CypD-regulated MPTP and cell death would assist in battling with these diseases.

AB - Numerous studies have deciphered the importance of Cyclophilin D (CypD/ peptidyl prolyl scis-trans isomerase F) in the formation and regulation of mitochondrial permeability transition pore (MPTP), implicated in the cell death mechanisms in various neurological diseases. Decrease in the ATP and increase in the calcium levels are the most common aftermath consequences that are observed in these diseases. Increased calcium level leads to the persistent opening of MPTP and cell death, which is mediated by CypD. However, the underlying mechanisms that contribute to the abnormal calcium homeostasis in different diseases remain elusive. In this review, we attempted to connect the disruption of mitochondrial bioenergetics with abnormal calcium levels and MPTP. Further, various proteins that interact with the CypD and the subsequent consequences have been described. All the cell death pathways in various neurological disorders merge at CypD, which acts as a key regulatory protein in cellular demise. Agents inhibiting CypD may have a therapeutic potential for treating neurological disorders such as Alzheimer’s disease, Parkinson’s disease and cerebral ischemia. Further, the knowledge regarding the pathophysiological processes involved in CypD-regulated MPTP and cell death would assist in battling with these diseases.

UR - http://www.scopus.com/inward/record.url?scp=84930518132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930518132&partnerID=8YFLogxK

U2 - 10.2174/1871527314666150429113239

DO - 10.2174/1871527314666150429113239

M3 - Article

VL - 14

SP - 654

EP - 663

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

SN - 1871-5273

IS - 5

ER -